Presentation

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

Presenter: Alexandre Abizaid

September 25, 2019

REGISTER for free or LOG IN to view this content

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

Coronary

Presentation

TCT 2019

DES/BRS/DCB

Up Next

Presentation

TCT 30: Ultra-Low Contrast Coronary Angiography in Patients with Advanced Chronic Kidney Disease – Feasibility and Outcomes Compared with Conventional Angiography

Presenter: NAVDEEP BHATTI

September 25, 2019

More slides +

Presentation

TCT 14: Assessment of the Sources of Near-infrared Auto-fluorescence in High-risk Coronary Artery Plaques: a Histopathologic Correlative Study

Presenter: Mie Kunio

September 25, 2019

Presentation

TCT 22: Impact of Transcatheter Aortic Valve Implantation on Microemboli 24 to 48 hours after Valve Implantation Observed as High Intensity Transient Signals on Transcranial Doppler: Prevelance and Implications

Presenter: Navneet Sharma

September 25, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.